Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy

Rosalba Gornati, Bruno Bembi, Xiaowei Tong, Rita Boscolo, Bruno Berra

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The follow-up of Gaucher's patients under enzyme replacement therapy is generally based both on the clinical aspects and the evaluation of haematological parameters: haemoglobin level, platelet count, acid and alkaline phosphatase activities. Spleen and liver volumes are also reliable criteria for evaluating the improvement of the patients. The determination of glycolipid excretion in the urine and/or the quantification of glycolipids in serum can also be a useful tool for the screening and the follow up of patients with lysosomal storage disease including Gaucher's disease. In this paper we report the follow-up of three patients with Gaucher type 3; in order to test the efficacy of the enzyme replacement therapy with alglucerase in these patients, we evaluated the urine and plasma glucosylceramide content as a marker parallel to the clinical improvement and the decreased organomegaly.

Original languageEnglish
Pages (from-to)151-161
Number of pages11
JournalClinica Chimica Acta
Volume271
Issue number2
DOIs
Publication statusPublished - Mar 23 1998

Fingerprint

Glucosylceramides
Enzyme Replacement Therapy
Gaucher Disease
Glycolipids
Urine
Enzymes
Acid Phosphatase
Platelets
Serum
Liver
Alkaline Phosphatase
Screening
Hemoglobins
Plasmas
Lysosomal Storage Diseases
Platelet Count
Spleen
alglucerase

Keywords

  • Enzyme replacement therapy
  • Gaucher type 3
  • Serum analysis
  • Urine analysis

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy. / Gornati, Rosalba; Bembi, Bruno; Tong, Xiaowei; Boscolo, Rita; Berra, Bruno.

In: Clinica Chimica Acta, Vol. 271, No. 2, 23.03.1998, p. 151-161.

Research output: Contribution to journalArticle

Gornati, Rosalba ; Bembi, Bruno ; Tong, Xiaowei ; Boscolo, Rita ; Berra, Bruno. / Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy. In: Clinica Chimica Acta. 1998 ; Vol. 271, No. 2. pp. 151-161.
@article{6d7ea96bd0a4449e84df3e04d0e98d6b,
title = "Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy",
abstract = "The follow-up of Gaucher's patients under enzyme replacement therapy is generally based both on the clinical aspects and the evaluation of haematological parameters: haemoglobin level, platelet count, acid and alkaline phosphatase activities. Spleen and liver volumes are also reliable criteria for evaluating the improvement of the patients. The determination of glycolipid excretion in the urine and/or the quantification of glycolipids in serum can also be a useful tool for the screening and the follow up of patients with lysosomal storage disease including Gaucher's disease. In this paper we report the follow-up of three patients with Gaucher type 3; in order to test the efficacy of the enzyme replacement therapy with alglucerase in these patients, we evaluated the urine and plasma glucosylceramide content as a marker parallel to the clinical improvement and the decreased organomegaly.",
keywords = "Enzyme replacement therapy, Gaucher type 3, Serum analysis, Urine analysis",
author = "Rosalba Gornati and Bruno Bembi and Xiaowei Tong and Rita Boscolo and Bruno Berra",
year = "1998",
month = "3",
day = "23",
doi = "10.1016/S0009-8981(97)00241-6",
language = "English",
volume = "271",
pages = "151--161",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy

AU - Gornati, Rosalba

AU - Bembi, Bruno

AU - Tong, Xiaowei

AU - Boscolo, Rita

AU - Berra, Bruno

PY - 1998/3/23

Y1 - 1998/3/23

N2 - The follow-up of Gaucher's patients under enzyme replacement therapy is generally based both on the clinical aspects and the evaluation of haematological parameters: haemoglobin level, platelet count, acid and alkaline phosphatase activities. Spleen and liver volumes are also reliable criteria for evaluating the improvement of the patients. The determination of glycolipid excretion in the urine and/or the quantification of glycolipids in serum can also be a useful tool for the screening and the follow up of patients with lysosomal storage disease including Gaucher's disease. In this paper we report the follow-up of three patients with Gaucher type 3; in order to test the efficacy of the enzyme replacement therapy with alglucerase in these patients, we evaluated the urine and plasma glucosylceramide content as a marker parallel to the clinical improvement and the decreased organomegaly.

AB - The follow-up of Gaucher's patients under enzyme replacement therapy is generally based both on the clinical aspects and the evaluation of haematological parameters: haemoglobin level, platelet count, acid and alkaline phosphatase activities. Spleen and liver volumes are also reliable criteria for evaluating the improvement of the patients. The determination of glycolipid excretion in the urine and/or the quantification of glycolipids in serum can also be a useful tool for the screening and the follow up of patients with lysosomal storage disease including Gaucher's disease. In this paper we report the follow-up of three patients with Gaucher type 3; in order to test the efficacy of the enzyme replacement therapy with alglucerase in these patients, we evaluated the urine and plasma glucosylceramide content as a marker parallel to the clinical improvement and the decreased organomegaly.

KW - Enzyme replacement therapy

KW - Gaucher type 3

KW - Serum analysis

KW - Urine analysis

UR - http://www.scopus.com/inward/record.url?scp=0032559778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032559778&partnerID=8YFLogxK

U2 - 10.1016/S0009-8981(97)00241-6

DO - 10.1016/S0009-8981(97)00241-6

M3 - Article

C2 - 9565330

AN - SCOPUS:0032559778

VL - 271

SP - 151

EP - 161

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 2

ER -